Journal: Inflammation
Article Title: Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway
doi: 10.1007/s10753-025-02403-4
Figure Lengend Snippet: Effect of HGN on RhoA inhibition of inflammation, oxidative stress, fibrosis and apoptosis in H9C2 cells. A Immunoblotting for RhoA (GAPDH as reference, n = 6). B Quantification of RhoA. C Immunoblotting for IL−6, TNF-α, IL−1β (GAPDH as reference, n = 6). D-F Quantification of IL−6, TNF-α, IL−1β. G Immunoblotting for GPX4, NRF2, Keap1 (GAPDH as control, n = 6). H-J Quantification of GPX4, NRF2, Keap1. K Immunoblotting for TGF-β1, α-SMA, Collagen I (GAPDH as control, n = 6). L-N Quantification of TGF-β1, α-SMA, Collagen I. O Immunoblotting for BCL2, Pro-Caspase−3, Cleaved Caspase−3, Pro-Caspase−9, Cleaved Caspase−9, RhoA (GAPDH as control, n = 6). P-S Quantification of BCL2, Pro-Caspase−3, Cleaved Caspase−3, Pro-Caspase−9, Cleaved Caspase−9. Significance: ns ( p > 0.05), * ( p < 0.05), ** ( p < 0.01), *** ( p < 0.001), **** ( p < 0.0001) vs. STZ group
Article Snippet: H9C2 mouse cardiomyocytes (CRL-1446; BSL 1; ATCC) were carefully maintained in a 37 °C, 5% CO2 and humidified incubator.
Techniques: Inhibition, Western Blot, Control